The novel therapy of the medication represents a exciting development in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide000920.worldblogged.com/48413075/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment